Request for Covid-19 Impact Assessment of this Report
The United States Risperidone market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Risperidone market, reaching US$ million by the year 2028. As for the Europe Risperidone landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Risperidone players cover Janssen Pharmaceutica, Teva, Sun Pharmaceutical, and Aurobindo, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Risperidone market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Oral
Injectable
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Schizophrenia
Bipolar Disorder
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Janssen Pharmaceutica
Teva
Sun Pharmaceutical
Aurobindo
Cipla
Invent Farma Group
Medichem
Interquim
IPCA
RPG
Sharon
Torrent Pharmaceuticals
Temad
Wuxi Jida
Changzhou Siyao Pharmaceuticals
Ningbo Team Pharm
Zhejiang Huahai Pharmaceutical
TIPR
Qilu Pharmaceutical
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Risperidone Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Risperidone by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Risperidone by Country/Region, 2017, 2022 & 2028
2.2 Risperidone Segment by Type
2.2.1 Oral
2.2.2 Injectable
2.3 Risperidone Sales by Type
2.3.1 Global Risperidone Sales Market Share by Type (2017-2022)
2.3.2 Global Risperidone Revenue and Market Share by Type (2017-2022)
2.3.3 Global Risperidone Sale Price by Type (2017-2022)
2.4 Risperidone Segment by Application
2.4.1 Schizophrenia
2.4.2 Bipolar Disorder
2.5 Risperidone Sales by Application
2.5.1 Global Risperidone Sale Market Share by Application (2017-2022)
2.5.2 Global Risperidone Revenue and Market Share by Application (2017-2022)
2.5.3 Global Risperidone Sale Price by Application (2017-2022)
3 Global Risperidone by Company
3.1 Global Risperidone Breakdown Data by Company
3.1.1 Global Risperidone Annual Sales by Company (2020-2022)
3.1.2 Global Risperidone Sales Market Share by Company (2020-2022)
3.2 Global Risperidone Annual Revenue by Company (2020-2022)
3.2.1 Global Risperidone Revenue by Company (2020-2022)
3.2.2 Global Risperidone Revenue Market Share by Company (2020-2022)
3.3 Global Risperidone Sale Price by Company
3.4 Key Manufacturers Risperidone Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Risperidone Product Location Distribution
3.4.2 Players Risperidone Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Risperidone by Geographic Region
4.1 World Historic Risperidone Market Size by Geographic Region (2017-2022)
4.1.1 Global Risperidone Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Risperidone Annual Revenue by Geographic Region
4.2 World Historic Risperidone Market Size by Country/Region (2017-2022)
4.2.1 Global Risperidone Annual Sales by Country/Region (2017-2022)
4.2.2 Global Risperidone Annual Revenue by Country/Region
4.3 Americas Risperidone Sales Growth
4.4 APAC Risperidone Sales Growth
4.5 Europe Risperidone Sales Growth
4.6 Middle East & Africa Risperidone Sales Growth
5 Americas
5.1 Americas Risperidone Sales by Country
5.1.1 Americas Risperidone Sales by Country (2017-2022)
5.1.2 Americas Risperidone Revenue by Country (2017-2022)
5.2 Americas Risperidone Sales by Type
5.3 Americas Risperidone Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Risperidone Sales by Region
6.1.1 APAC Risperidone Sales by Region (2017-2022)
6.1.2 APAC Risperidone Revenue by Region (2017-2022)
6.2 APAC Risperidone Sales by Type
6.3 APAC Risperidone Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Risperidone by Country
7.1.1 Europe Risperidone Sales by Country (2017-2022)
7.1.2 Europe Risperidone Revenue by Country (2017-2022)
7.2 Europe Risperidone Sales by Type
7.3 Europe Risperidone Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Risperidone by Country
8.1.1 Middle East & Africa Risperidone Sales by Country (2017-2022)
8.1.2 Middle East & Africa Risperidone Revenue by Country (2017-2022)
8.2 Middle East & Africa Risperidone Sales by Type
8.3 Middle East & Africa Risperidone Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Risperidone
10.3 Manufacturing Process Analysis of Risperidone
10.4 Industry Chain Structure of Risperidone
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Risperidone Distributors
11.3 Risperidone Customer
12 World Forecast Review for Risperidone by Geographic Region
12.1 Global Risperidone Market Size Forecast by Region
12.1.1 Global Risperidone Forecast by Region (2023-2028)
12.1.2 Global Risperidone Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Risperidone Forecast by Type
12.7 Global Risperidone Forecast by Application
13 Key Players Analysis
13.1 Janssen Pharmaceutica
13.1.1 Janssen Pharmaceutica Company Information
13.1.2 Janssen Pharmaceutica Risperidone Product Offered
13.1.3 Janssen Pharmaceutica Risperidone Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Janssen Pharmaceutica Main Business Overview
13.1.5 Janssen Pharmaceutica Latest Developments
13.2 Teva
13.2.1 Teva Company Information
13.2.2 Teva Risperidone Product Offered
13.2.3 Teva Risperidone Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Teva Main Business Overview
13.2.5 Teva Latest Developments
13.3 Sun Pharmaceutical
13.3.1 Sun Pharmaceutical Company Information
13.3.2 Sun Pharmaceutical Risperidone Product Offered
13.3.3 Sun Pharmaceutical Risperidone Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Sun Pharmaceutical Main Business Overview
13.3.5 Sun Pharmaceutical Latest Developments
13.4 Aurobindo
13.4.1 Aurobindo Company Information
13.4.2 Aurobindo Risperidone Product Offered
13.4.3 Aurobindo Risperidone Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Aurobindo Main Business Overview
13.4.5 Aurobindo Latest Developments
13.5 Cipla
13.5.1 Cipla Company Information
13.5.2 Cipla Risperidone Product Offered
13.5.3 Cipla Risperidone Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Cipla Main Business Overview
13.5.5 Cipla Latest Developments
13.6 Invent Farma Group
13.6.1 Invent Farma Group Company Information
13.6.2 Invent Farma Group Risperidone Product Offered
13.6.3 Invent Farma Group Risperidone Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Invent Farma Group Main Business Overview
13.6.5 Invent Farma Group Latest Developments
13.7 Medichem
13.7.1 Medichem Company Information
13.7.2 Medichem Risperidone Product Offered
13.7.3 Medichem Risperidone Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Medichem Main Business Overview
13.7.5 Medichem Latest Developments
13.8 Interquim
13.8.1 Interquim Company Information
13.8.2 Interquim Risperidone Product Offered
13.8.3 Interquim Risperidone Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Interquim Main Business Overview
13.8.5 Interquim Latest Developments
13.9 IPCA
13.9.1 IPCA Company Information
13.9.2 IPCA Risperidone Product Offered
13.9.3 IPCA Risperidone Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 IPCA Main Business Overview
13.9.5 IPCA Latest Developments
13.10 RPG
13.10.1 RPG Company Information
13.10.2 RPG Risperidone Product Offered
13.10.3 RPG Risperidone Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 RPG Main Business Overview
13.10.5 RPG Latest Developments
13.11 Sharon
13.11.1 Sharon Company Information
13.11.2 Sharon Risperidone Product Offered
13.11.3 Sharon Risperidone Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Sharon Main Business Overview
13.11.5 Sharon Latest Developments
13.12 Torrent Pharmaceuticals
13.12.1 Torrent Pharmaceuticals Company Information
13.12.2 Torrent Pharmaceuticals Risperidone Product Offered
13.12.3 Torrent Pharmaceuticals Risperidone Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Torrent Pharmaceuticals Main Business Overview
13.12.5 Torrent Pharmaceuticals Latest Developments
13.13 Temad
13.13.1 Temad Company Information
13.13.2 Temad Risperidone Product Offered
13.13.3 Temad Risperidone Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Temad Main Business Overview
13.13.5 Temad Latest Developments
13.14 Wuxi Jida
13.14.1 Wuxi Jida Company Information
13.14.2 Wuxi Jida Risperidone Product Offered
13.14.3 Wuxi Jida Risperidone Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Wuxi Jida Main Business Overview
13.14.5 Wuxi Jida Latest Developments
13.15 Changzhou Siyao Pharmaceuticals
13.15.1 Changzhou Siyao Pharmaceuticals Company Information
13.15.2 Changzhou Siyao Pharmaceuticals Risperidone Product Offered
13.15.3 Changzhou Siyao Pharmaceuticals Risperidone Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Changzhou Siyao Pharmaceuticals Main Business Overview
13.15.5 Changzhou Siyao Pharmaceuticals Latest Developments
13.16 Ningbo Team Pharm
13.16.1 Ningbo Team Pharm Company Information
13.16.2 Ningbo Team Pharm Risperidone Product Offered
13.16.3 Ningbo Team Pharm Risperidone Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Ningbo Team Pharm Main Business Overview
13.16.5 Ningbo Team Pharm Latest Developments
13.17 Zhejiang Huahai Pharmaceutical
13.17.1 Zhejiang Huahai Pharmaceutical Company Information
13.17.2 Zhejiang Huahai Pharmaceutical Risperidone Product Offered
13.17.3 Zhejiang Huahai Pharmaceutical Risperidone Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Zhejiang Huahai Pharmaceutical Main Business Overview
13.17.5 Zhejiang Huahai Pharmaceutical Latest Developments
13.18 TIPR
13.18.1 TIPR Company Information
13.18.2 TIPR Risperidone Product Offered
13.18.3 TIPR Risperidone Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 TIPR Main Business Overview
13.18.5 TIPR Latest Developments
13.19 Qilu Pharmaceutical
13.19.1 Qilu Pharmaceutical Company Information
13.19.2 Qilu Pharmaceutical Risperidone Product Offered
13.19.3 Qilu Pharmaceutical Risperidone Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 Qilu Pharmaceutical Main Business Overview
13.19.5 Qilu Pharmaceutical Latest Developments
14 Research Findings and Conclusion
Table 1. Risperidone Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Risperidone Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of Injectable
Table 5. Global Risperidone Sales by Type (2017-2022) & (K Pcs)
Table 6. Global Risperidone Sales Market Share by Type (2017-2022)
Table 7. Global Risperidone Revenue by Type (2017-2022) & ($ million)
Table 8. Global Risperidone Revenue Market Share by Type (2017-2022)
Table 9. Global Risperidone Sale Price by Type (2017-2022) & (USD/Pcs)
Table 10. Global Risperidone Sales by Application (2017-2022) & (K Pcs)
Table 11. Global Risperidone Sales Market Share by Application (2017-2022)
Table 12. Global Risperidone Revenue by Application (2017-2022)
Table 13. Global Risperidone Revenue Market Share by Application (2017-2022)
Table 14. Global Risperidone Sale Price by Application (2017-2022) & (USD/Pcs)
Table 15. Global Risperidone Sales by Company (2020-2022) & (K Pcs)
Table 16. Global Risperidone Sales Market Share by Company (2020-2022)
Table 17. Global Risperidone Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Risperidone Revenue Market Share by Company (2020-2022)
Table 19. Global Risperidone Sale Price by Company (2020-2022) & (USD/Pcs)
Table 20. Key Manufacturers Risperidone Producing Area Distribution and Sales Area
Table 21. Players Risperidone Products Offered
Table 22. Risperidone Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Risperidone Sales by Geographic Region (2017-2022) & (K Pcs)
Table 26. Global Risperidone Sales Market Share Geographic Region (2017-2022)
Table 27. Global Risperidone Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Risperidone Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Risperidone Sales by Country/Region (2017-2022) & (K Pcs)
Table 30. Global Risperidone Sales Market Share by Country/Region (2017-2022)
Table 31. Global Risperidone Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Risperidone Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Risperidone Sales by Country (2017-2022) & (K Pcs)
Table 34. Americas Risperidone Sales Market Share by Country (2017-2022)
Table 35. Americas Risperidone Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Risperidone Revenue Market Share by Country (2017-2022)
Table 37. Americas Risperidone Sales by Type (2017-2022) & (K Pcs)
Table 38. Americas Risperidone Sales Market Share by Type (2017-2022)
Table 39. Americas Risperidone Sales by Application (2017-2022) & (K Pcs)
Table 40. Americas Risperidone Sales Market Share by Application (2017-2022)
Table 41. APAC Risperidone Sales by Region (2017-2022) & (K Pcs)
Table 42. APAC Risperidone Sales Market Share by Region (2017-2022)
Table 43. APAC Risperidone Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Risperidone Revenue Market Share by Region (2017-2022)
Table 45. APAC Risperidone Sales by Type (2017-2022) & (K Pcs)
Table 46. APAC Risperidone Sales Market Share by Type (2017-2022)
Table 47. APAC Risperidone Sales by Application (2017-2022) & (K Pcs)
Table 48. APAC Risperidone Sales Market Share by Application (2017-2022)
Table 49. Europe Risperidone Sales by Country (2017-2022) & (K Pcs)
Table 50. Europe Risperidone Sales Market Share by Country (2017-2022)
Table 51. Europe Risperidone Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Risperidone Revenue Market Share by Country (2017-2022)
Table 53. Europe Risperidone Sales by Type (2017-2022) & (K Pcs)
Table 54. Europe Risperidone Sales Market Share by Type (2017-2022)
Table 55. Europe Risperidone Sales by Application (2017-2022) & (K Pcs)
Table 56. Europe Risperidone Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Risperidone Sales by Country (2017-2022) & (K Pcs)
Table 58. Middle East & Africa Risperidone Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Risperidone Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Risperidone Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Risperidone Sales by Type (2017-2022) & (K Pcs)
Table 62. Middle East & Africa Risperidone Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Risperidone Sales by Application (2017-2022) & (K Pcs)
Table 64. Middle East & Africa Risperidone Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Risperidone
Table 66. Key Market Challenges & Risks of Risperidone
Table 67. Key Industry Trends of Risperidone
Table 68. Risperidone Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Risperidone Distributors List
Table 71. Risperidone Customer List
Table 72. Global Risperidone Sales Forecast by Region (2023-2028) & (K Pcs)
Table 73. Global Risperidone Sales Market Forecast by Region
Table 74. Global Risperidone Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Risperidone Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Risperidone Sales Forecast by Country (2023-2028) & (K Pcs)
Table 77. Americas Risperidone Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Risperidone Sales Forecast by Region (2023-2028) & (K Pcs)
Table 79. APAC Risperidone Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Risperidone Sales Forecast by Country (2023-2028) & (K Pcs)
Table 81. Europe Risperidone Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Risperidone Sales Forecast by Country (2023-2028) & (K Pcs)
Table 83. Middle East & Africa Risperidone Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Risperidone Sales Forecast by Type (2023-2028) & (K Pcs)
Table 85. Global Risperidone Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Risperidone Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Risperidone Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Risperidone Sales Forecast by Application (2023-2028) & (K Pcs)
Table 89. Global Risperidone Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Risperidone Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Risperidone Revenue Market Share Forecast by Application (2023-2028)
Table 92. Janssen Pharmaceutica Basic Information, Risperidone Manufacturing Base, Sales Area and Its Competitors
Table 93. Janssen Pharmaceutica Risperidone Product Offered
Table 94. Janssen Pharmaceutica Risperidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 95. Janssen Pharmaceutica Main Business
Table 96. Janssen Pharmaceutica Latest Developments
Table 97. Teva Basic Information, Risperidone Manufacturing Base, Sales Area and Its Competitors
Table 98. Teva Risperidone Product Offered
Table 99. Teva Risperidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 100. Teva Main Business
Table 101. Teva Latest Developments
Table 102. Sun Pharmaceutical Basic Information, Risperidone Manufacturing Base, Sales Area and Its Competitors
Table 103. Sun Pharmaceutical Risperidone Product Offered
Table 104. Sun Pharmaceutical Risperidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 105. Sun Pharmaceutical Main Business
Table 106. Sun Pharmaceutical Latest Developments
Table 107. Aurobindo Basic Information, Risperidone Manufacturing Base, Sales Area and Its Competitors
Table 108. Aurobindo Risperidone Product Offered
Table 109. Aurobindo Risperidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 110. Aurobindo Main Business
Table 111. Aurobindo Latest Developments
Table 112. Cipla Basic Information, Risperidone Manufacturing Base, Sales Area and Its Competitors
Table 113. Cipla Risperidone Product Offered
Table 114. Cipla Risperidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 115. Cipla Main Business
Table 116. Cipla Latest Developments
Table 117. Invent Farma Group Basic Information, Risperidone Manufacturing Base, Sales Area and Its Competitors
Table 118. Invent Farma Group Risperidone Product Offered
Table 119. Invent Farma Group Risperidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 120. Invent Farma Group Main Business
Table 121. Invent Farma Group Latest Developments
Table 122. Medichem Basic Information, Risperidone Manufacturing Base, Sales Area and Its Competitors
Table 123. Medichem Risperidone Product Offered
Table 124. Medichem Risperidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 125. Medichem Main Business
Table 126. Medichem Latest Developments
Table 127. Interquim Basic Information, Risperidone Manufacturing Base, Sales Area and Its Competitors
Table 128. Interquim Risperidone Product Offered
Table 129. Interquim Risperidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 130. Interquim Main Business
Table 131. Interquim Latest Developments
Table 132. IPCA Basic Information, Risperidone Manufacturing Base, Sales Area and Its Competitors
Table 133. IPCA Risperidone Product Offered
Table 134. IPCA Risperidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 135. IPCA Main Business
Table 136. IPCA Latest Developments
Table 137. RPG Basic Information, Risperidone Manufacturing Base, Sales Area and Its Competitors
Table 138. RPG Risperidone Product Offered
Table 139. RPG Risperidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 140. RPG Main Business
Table 141. RPG Latest Developments
Table 142. Sharon Basic Information, Risperidone Manufacturing Base, Sales Area and Its Competitors
Table 143. Sharon Risperidone Product Offered
Table 144. Sharon Risperidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 145. Sharon Main Business
Table 146. Sharon Latest Developments
Table 147. Torrent Pharmaceuticals Basic Information, Risperidone Manufacturing Base, Sales Area and Its Competitors
Table 148. Torrent Pharmaceuticals Risperidone Product Offered
Table 149. Torrent Pharmaceuticals Risperidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 150. Torrent Pharmaceuticals Main Business
Table 151. Torrent Pharmaceuticals Latest Developments
Table 152. Temad Basic Information, Risperidone Manufacturing Base, Sales Area and Its Competitors
Table 153. Temad Risperidone Product Offered
Table 154. Temad Risperidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 155. Temad Main Business
Table 156. Temad Latest Developments
Table 157. Wuxi Jida Basic Information, Risperidone Manufacturing Base, Sales Area and Its Competitors
Table 158. Wuxi Jida Risperidone Product Offered
Table 159. Wuxi Jida Risperidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 160. Wuxi Jida Main Business
Table 161. Wuxi Jida Latest Developments
Table 162. Changzhou Siyao Pharmaceuticals Basic Information, Risperidone Manufacturing Base, Sales Area and Its Competitors
Table 163. Changzhou Siyao Pharmaceuticals Risperidone Product Offered
Table 164. Changzhou Siyao Pharmaceuticals Risperidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 165. Changzhou Siyao Pharmaceuticals Main Business
Table 166. Changzhou Siyao Pharmaceuticals Latest Developments
Table 167. Ningbo Team Pharm Basic Information, Risperidone Manufacturing Base, Sales Area and Its Competitors
Table 168. Ningbo Team Pharm Risperidone Product Offered
Table 169. Ningbo Team Pharm Risperidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 170. Ningbo Team Pharm Main Business
Table 171. Ningbo Team Pharm Latest Developments
Table 172. Zhejiang Huahai Pharmaceutical Basic Information, Risperidone Manufacturing Base, Sales Area and Its Competitors
Table 173. Zhejiang Huahai Pharmaceutical Risperidone Product Offered
Table 174. Zhejiang Huahai Pharmaceutical Risperidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 175. Zhejiang Huahai Pharmaceutical Main Business
Table 176. Zhejiang Huahai Pharmaceutical Latest Developments
Table 177. TIPR Basic Information, Risperidone Manufacturing Base, Sales Area and Its Competitors
Table 178. TIPR Risperidone Product Offered
Table 179. TIPR Risperidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 180. TIPR Main Business
Table 181. TIPR Latest Developments
Table 182. Qilu Pharmaceutical Basic Information, Risperidone Manufacturing Base, Sales Area and Its Competitors
Table 183. Qilu Pharmaceutical Risperidone Product Offered
Table 184. Qilu Pharmaceutical Risperidone Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 185. Qilu Pharmaceutical Main Business
Table 186. Qilu Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Risperidone
Figure 2. Risperidone Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Risperidone Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Risperidone Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Risperidone Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Oral
Figure 10. Product Picture of Injectable
Figure 11. Global Risperidone Sales Market Share by Type in 2021
Figure 12. Global Risperidone Revenue Market Share by Type (2017-2022)
Figure 13. Risperidone Consumed in Schizophrenia
Figure 14. Global Risperidone Market: Schizophrenia (2017-2022) & (K Pcs)
Figure 15. Risperidone Consumed in Bipolar Disorder
Figure 16. Global Risperidone Market: Bipolar Disorder (2017-2022) & (K Pcs)
Figure 17. Global Risperidone Sales Market Share by Application (2017-2022)
Figure 18. Global Risperidone Revenue Market Share by Application in 2021
Figure 19. Risperidone Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Risperidone Revenue Market Share by Company in 2021
Figure 21. Global Risperidone Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Risperidone Revenue Market Share by Geographic Region in 2021
Figure 23. Global Risperidone Sales Market Share by Region (2017-2022)
Figure 24. Global Risperidone Revenue Market Share by Country/Region in 2021
Figure 25. Americas Risperidone Sales 2017-2022 (K Pcs)
Figure 26. Americas Risperidone Revenue 2017-2022 ($ Millions)
Figure 27. APAC Risperidone Sales 2017-2022 (K Pcs)
Figure 28. APAC Risperidone Revenue 2017-2022 ($ Millions)
Figure 29. Europe Risperidone Sales 2017-2022 (K Pcs)
Figure 30. Europe Risperidone Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Risperidone Sales 2017-2022 (K Pcs)
Figure 32. Middle East & Africa Risperidone Revenue 2017-2022 ($ Millions)
Figure 33. Americas Risperidone Sales Market Share by Country in 2021
Figure 34. Americas Risperidone Revenue Market Share by Country in 2021
Figure 35. United States Risperidone Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Risperidone Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Risperidone Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Risperidone Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Risperidone Sales Market Share by Region in 2021
Figure 40. APAC Risperidone Revenue Market Share by Regions in 2021
Figure 41. China Risperidone Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Risperidone Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Risperidone Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Risperidone Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Risperidone Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Risperidone Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Risperidone Sales Market Share by Country in 2021
Figure 48. Europe Risperidone Revenue Market Share by Country in 2021
Figure 49. Germany Risperidone Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Risperidone Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Risperidone Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Risperidone Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Risperidone Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Risperidone Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Risperidone Revenue Market Share by Country in 2021
Figure 56. Egypt Risperidone Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Risperidone Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Risperidone Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Risperidone Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Risperidone Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Risperidone in 2021
Figure 62. Manufacturing Process Analysis of Risperidone
Figure 63. Industry Chain Structure of Risperidone
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...